Dr. Valerie C Wasinger

Dr. Valerie Wasinger received her PhD from the University of Sydney, Australia, in 1999, and has worked at the DKFZ, University of Heidelberg, Germany, the Garvan Institute of Medical Research, Sydney, and is currently at the University of New South Wales, Sydney. She is a senior research scientist and conjoint lecturer at the Bioanalytical Mass Spectrometry Facility, MWAC, at UNSW Sydney. Dr. Wasinger is the first author of the publication defining the field of proteomics, published in 1995. Her research focuses on the advancement of analytical techniques fostering the accurate and sensitive measurement of peptides and proteins within the context of mass spectrometry-based analysis of the proteome and metabolome. She has a background in microbiology and is keenly interested in improving the detection of low-mass endogenous proteins and peptides and translating this into tangible methods to deepen understanding of biological processes. Dr. Wasinger's research focuses on a variety of medical diseases, with more than 10 years' experience in developing biotech and proteomic solutions for inflammatory bowel disease (IBD), autoimmune diseases, and cancer, as well as methodologies for forensic and paleo-proteomic and bio-archaeological research. Her recent work has led to two patents in the IBD sphere.